Concepedia

Author

Federica Guffanti

Mario Negri Institute for Pharmacological ResearchORCID

Also Known As

F. Guffanti, FEDERICA GUFFANTI, Federica Guffanti, Guffanti, Federica

75

Publications

901

Citations

16

H-Index

21

Concepts

All Affiliations

Mario Negri Institute for Pharmacological ResearchIstituti di Ricovero e Cura a Carattere ScientificoUniversity of Milano-BicoccaUniversity of MilanAzienda Ospedaliera San Gerardo
FG

About

Federica Guffanti is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

281

2

Cell Biology

6

6

281

3

Obstetrics

3

3

189

4

Health Sciences

1

1

28

5

Immunology

1

1

25

Federica Guffanti

×

16

Publications

502

Citations

13

H-Index

YearCitations

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

Francesca Ricci, Francesca Bizzaro, Marta Cesca,

Cancer Research

2014

127

Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma

Rosaria Chilà, Alessandra Basana, Monica Lupi,

Oncotarget

2014

62

LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors

Elisa Caiola, Alice Iezzi, Michele Tomanelli,

Journal of Thoracic Oncology

2019

47

In Vitro and In Vivo Activity of Lucitanib in FGFR1/2 Amplified or Mutated Cancer Models

Federica Guffanti, Rosaria Chilà, Ezia Bello,

Neoplasia

2016

34

Basal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts

Federica Guffanti, M.F. Alvisi, Alessia Anastasia,

British Journal of Cancer

2021

34

Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy

Francesca Ricci, Maddalena Fratelli, Federica Guffanti,

Oncotarget

2016

28

Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts

Denise Pinessi, Paola Ostano, Patrizia Borsotti,

Connective Tissue Research

2015

25

Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth

Ouma Cisse, Muzthahid Quraishi, Federico Gulluni,

Journal of Experimental & Clinical Cancer Research

2019

23

Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells

Michela Chiappa, Federica Guffanti, Martina Anselmi,

Cancers

2022

22

Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy

Aikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya,

Cancers

2020

20

Page 1